Dextran as a plasma volume substitute.
D000707:Anaphylaxis / Q000209:etiology; D000818:Animals; D000917:Antibody Formation; D003911:Dextrans / Q000378:metabolism / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004903:Erythrocyte Aggregation / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007934:Leuconostoc / Q000378:metabolism; D008968:Molecular Conformation; D008970:Molecular Weight; D010952:Plasma Substitutes; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000517:prevention & control; D012771:Shock, Hemorrhagic / Q000628:therapy; D013395:Sucrose / Q000378:metabolism; D013924:Thrombophlebitis / Q000517:prevention & control
D003911:Dextrans; D010952:Plasma Substitutes; D013395:Sucrose